| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.65▼ | 0.65▼ | 0.65▼ | 0.66▼ | 0.73▼ |
| MA10 | 0.71▼ | 0.71▼ | 0.71▼ | 0.67▼ | 0.74▼ |
| MA20 | 0.74▼ | 0.74▼ | 0.74▼ | 0.72▼ | 0.64▲ |
| MA50 | 0.78▼ | 0.77▼ | 0.76▼ | 0.73▼ | 0.91▼ |
| MA100 | 0.73▼ | 0.71▼ | 0.70▼ | 0.63▲ | 1.68▼ |
| MA200 | 0.67▼ | 0.62▲ | 0.61▲ | 0.80▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.013▼ | -0.014▼ | -0.015▼ | -0.011▼ | 0.031▲ |
| RSI | 34.586▼ | 35.006▼ | 35.270▼ | 39.538▼ | 41.962▼ |
| STOCH | 9.672▼ | 9.672▼ | 9.672▼ | 41.390 | 58.273 |
| WILL %R | -98.828▼ | -98.828▼ | -98.828▼ | -72.443 | -57.167 |
| CCI | -119.413▼ | -119.413▼ | -119.413▼ | -85.097 | -31.110 |
|
Wednesday, April 24, 2024 04:00 AM
Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/04/24 | 0.6394 | 0.6464 | 0.62 | 0.6399 | 23,560 |
| 25/04/24 | 0.67 | 0.68 | 0.6325 | 0.659 | 11,541 |
| 24/04/24 | 0.68 | 0.68 | 0.65 | 0.67 | 3,424 |
| 23/04/24 | 0.644 | 0.6799 | 0.644 | 0.67 | 7,157 |
| 22/04/24 | 0.665 | 0.665 | 0.6219 | 0.6599 | 9,538 |
| 19/04/24 | 0.70 | 0.7399 | 0.657 | 0.68 | 15,577 |
| 18/04/24 | 0.62 | 0.70 | 0.62 | 0.70 | 29,723 |
| 17/04/24 | 0.6935 | 0.6949 | 0.579 | 0.59 | 48,946 |
| 16/04/24 | 0.70 | 0.74 | 0.6602 | 0.6607 | 38,055 |
| 15/04/24 | 0.751 | 0.7697 | 0.72 | 0.73 | 50,262 |
|
|
||||
|
|
||||
|
|